![Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba | ACS Omega Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.2c06451/asset/images/large/ao2c06451_0013.jpeg)
Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba | ACS Omega
![Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/915bbef7-9922-426d-ad4f-c570a2d3183c/jnc14687-toc-0001-m.jpg?trick=1694380553863)
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
![Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases](https://www.mdpi.com/cells/cells-09-01627/article_deploy/html/images/cells-09-01627-g001.png)